<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03741998</url>
  </required_header>
  <id_info>
    <org_study_id>RenJiH[2018]011</org_study_id>
    <nct_id>NCT03741998</nct_id>
  </id_info>
  <brief_title>Nasopharyngeal Airway Facilitate Transnasal Humidified Rapid Insufflation Ventilatory Exchange</brief_title>
  <official_title>Nasopharyngeal Airway Facilitate Transnasal Humidified Rapid Insufflation Ventilatory Exchange</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For performing transnasal humidified rapid insufflation ventilatory exchange (THRIVE),
      jaw-thrust maneuver have to maintain to make sure the airway open and the CO2 clearance
      during apnoea. The objective of present study is to prove that nasopharyngeal airway
      facilitate THRIVE and no need jaw-thrust maneuver and maintain the similar PO2 and PCO2
      during apnoea.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 7, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The partial pressure of carbon dioxide (pCO2)</measure>
    <time_frame>From start to end of THRIVE(20 minutes)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The partial pressure of oxygen(PO2)</measure>
    <time_frame>From start to end of THRIVE(20 minutes)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hypoxia</condition>
  <condition>Hypercapnia</condition>
  <arm_group>
    <arm_group_label>THRIVE</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during induction using jaw-thrust maneuver.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>THRIVE with nasopharyngeal airway</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during induction with nasopharyngeal airway.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasopharyngeal airway</intervention_name>
    <description>THRIVE with a regular nasopharyngeal airway.</description>
    <arm_group_label>THRIVE with nasopharyngeal airway</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent.

          -  Undergoing surgery with general anaesthesia.

          -  Adult, &gt;18 years old.

          -  American Society of Anesthesiology classification I-II.

        Exclusion Criteria:

          -  Coagulation disorders or a tendency of nose bleeding

          -  An episode/exacerbation of congestive heart failure (CHF) that requires a change in
             medication, diet or hospitalization from any cause in the last 6 months

          -  Severe aortic stenosis or mitral stenosis;

          -  Cardiac surgery involving thoracotomy (e.g., coronary artery bypass graft (CABG),
             valve replacement surgery) in the last 6 months;

          -  Acute myocardial infarction in the last 6 months;

          -  Acute arrhythmia (including both tachycardia and bradycardia) with hemodynamic
             instability;

          -  Diagnosed COPD or current other acute or chronic lung disease requiring supplemental
             chronic or intermittent oxygen therapy);

          -  Increased intracranial pressure;

          -  ASA &gt;II;

          -  Mouth, nose, or throat infection;

          -  Fever, defined as core body temperature &gt; 37.5Â°C;

          -  Pregnancy, breastfeeding or positive pregnancy test;

          -  Emergency procedure.

          -  Patient with known or suspected difficult airway
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diansan Su, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diansan Su, Dr.</last_name>
    <phone>+862168383702</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>diansan su, Dr.</last_name>
      <phone>+862168383702</phone>
      <email>diansansu@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>November 12, 2018</study_first_submitted>
  <study_first_submitted_qc>November 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2018</study_first_posted>
  <last_update_submitted>July 18, 2019</last_update_submitted>
  <last_update_submitted_qc>July 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

